Caifeng Jia, Sen Zhang, Jie Wang, Bing Feng, Fenghao Shi, Meiqi Wang, Sainan Li, Hao Xu, Mingxia Wang. "Cost-effectiveness of CDK4/6 inhibitors for second-line HR+/HER2− advanced or metastatic breast cancer in China." Scientific Reports, 2025. doi:10.1038/s41598-025-97504-3